Breast Neoplasms: all 12,820 studies
Page 91 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast CancerCompletedNCT02681120
- APBI: 27Gy in 5 Fractions for Early Breast CancerStatus unknownNCT02681107Not applicable
- Factors and Perceptions Affecting Treatment Choices of Breast Cancer PatientsStatus unknownNCT02679638
- Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant ChemotherapyCompletedNCT02679586Early Phase 1
- Developing a Healthy Lifestyle in Breast Cancer SurvivorsTerminatedNCT02677857Not applicable
- Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in WisconsinCompletedNCT02677389Not applicable
- Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast CancerCompletedNCT02676986Phase 2
- Walking Meditation Exercise in Breast Cancer PatientsCompletedNCT02676531Not applicable
- Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast CancerCompletedNCT02672475Phase 1
- Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric SymptomsCompletedNCT02672189Phase 3
- Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast CancerStatus unknownNCT02670668Not applicable
- A Trial of Evonail® Solution for Prevention or Treatment of OnycholysisCompletedNCT02670603Not applicable
- Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective RegistryCompletedNCT02670577
- Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer PatientsStatus unknownNCT02670109Phase 2
- The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer PatientsCompletedNCT02669745
- Mind-Body Medicine Day Care Clinic in Breast Cancer Patients Undergoing Endocrine TherapyCompletedNCT02669576Not applicable
- Imaging Markers of Subclinical Cardiotoxicity in Breast CancerCompletedNCT02666378
- A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in GermanyCompletedNCT02666261
- The LightPath® Breast Cancer StudyStatus unknownNCT02666079Not applicable
- Effectiveness of Tailored Rehabilitation Education on Health Literacy and Health Status of Postoperative Patients With Breast Cancer: a Randomized Controlled TrialCompletedNCT02664662Not applicable
- Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary PresentationTerminatedNCT02664389Not applicable
- Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast CancerCompletedNCT02664103Phase 2
- Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA IIICompletedNCT02663973
- Metastatic Breast Cancer in Brazil: Characterization of Patients and TreatmentsCompletedNCT02662868
- Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer SurvivorsCompletedNCT02662335Not applicable
- Fertility Preservation in Breast Cancer PatientsCompletedNCT02661932Phase 4
- Bright Light on Fatigue in Women Being Treated for Breast CancerCompletedNCT02658708Phase 1
- Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
- Hypnosis to Reduce Aromatase Inhibitor Pain and Improve AdherenceCompletedNCT02657993Not applicable
- microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With HerceptinStatus unknownNCT02656589
- Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical PracticeTerminatedNCT02655159
- Identification and Semi-Quantification of Ki-67 Protein Expression StatusCompletedNCT02654457
- Semi-Quantification of Her2/Neu Protein Expression in Formalin Fixed, Paraffin-Embedded Normal and Neoplastic TissueCompletedNCT02654444
- Identification and Semi -Quantification of ER/PR Proteins ExpressionCompletedNCT02654431
- Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional EndotheliumCompletedNCT02652975Not applicable
- Contrast Ultrasound Detection of Sentinel Lymph NodesCompletedNCT02652923Phase 1/2
- Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.CompletedNCT02651844Not applicable
- Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast CancerWithdrawnNCT02651610Phase 2/3
- Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast CancerStatus unknownNCT02651142Not applicable
- Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast CancerCompletedNCT02650817Phase 1
- Automated Breast Ultrasound ScreeningCompletedNCT02650778
- Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) MetastasesCompletedNCT02650752Phase 1
- Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing PositivelyCompletedNCT02650661Not applicable
- TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsTerminatedNCT02650635Phase 1
- Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving TrastuzumabCompletedNCT02649686Phase 1
- Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast CancerStatus unknownNCT02649101Phase 2
- Cavity Shaving in Breast Conserving Surgery for Breast Cancer PatientsCompletedNCT02648802Not applicable
- Mindfulness for Breast CancerCompletedNCT02647216Not applicable
- Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer PatientsStatus unknownNCT02646735Phase 2
- Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
- Improving Surgical Decision-making in Young Women With Breast CancerCompletedNCT02644382
- Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer PatientsStatus unknownNCT02642458
- Therapy Management With Nab-Paclitaxel in Daily RoutineStatus unknownNCT02642406
- TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA SignatureActive, not recruitingNCT02641847Phase 2/3
- A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.Status unknownNCT02639832
- Novel Social Media Intervention For Older Br CA PatientsCompletedNCT02639208Not applicable
- Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic CancersCompletedNCT02639026Phase 1
- Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 LesionsCompletedNCT02638935Not applicable
- Life ImproVed by Exercise (LIVE Trial)CompletedNCT02637765Not applicable
- Does Autologous Fat Transplantation Improve Results and Reduce Complications in Breast Reconstruction With Implants?Status unknownNCT02637635Not applicable
- Vortioxetine for MDD, Cognition, and Systemic Inflammatory BiomarkersWithdrawnNCT02637466Phase 4
- A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast CancerWithdrawnNCT02637375Not applicable
- Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast IrradiationCompletedNCT02637024Phase 2
- A Study of LY2880070 in Participants With Advanced or Metastatic CancerCompletedNCT02632448Phase 1/2
- Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.CompletedNCT02632435Not applicable
- ACY-1215 + Nab-paclitaxel in Metastatic Breast CancerCompletedNCT02632071Phase 1
- A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)Status unknownNCT02630368Phase 1/2
- Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 VariationsCompletedNCT02628613Phase 2
- Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer PatientsCompletedNCT02628132Phase 1/2
- Breast Edema Compression VestCompletedNCT02627976Not applicable
- (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast CancerStatus unknownNCT02627703
- The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing MastectomyCompletedNCT02627560Phase 4
- Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast CancerWithdrawnNCT02627430Phase 1
- Tumor Bed Dose Delivery Using A Breast Specific Radiosurgery Device, The Gammapod: (A Clinical Feasibility Study)Status unknownNCT02627313Not applicable
- Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast CancerStatus unknownNCT02626507Phase 1
- Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatientsCompletedNCT02626039
- Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in GreeceCompletedNCT02626013
- Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer PatientsCompletedNCT02625935
- Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast CancerActive, not recruitingNCT02625441Phase 3
- PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC TrialActive, not recruitingNCT02624973Phase 2
- Study of KHK2375 in Subjects With Advanced or Recurrent Breast CancerCompletedNCT02623751Phase 1
- Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast CancerCompletedNCT02622711Not applicable
- Impact of Osteopathy on Pain After Breast Cancer SurgeryCompletedNCT02621437Not applicable
- Hybrid Gamma Camera in Breast SurgeryWithdrawnNCT02621099
- Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:ProtocolCompletedNCT02620735Not applicable
- Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1CompletedNCT02620280Phase 3
- Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and AustriaCompletedNCT02619929
- Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast CancerWithdrawnNCT02619669Phase 1
- Mindful Movement for Breast Cancer SurvivorsCompletedNCT02619292Not applicable
- Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and PharmacodynamicsCompletedNCT02619162Phase 1
- Tailored Screening for Breast Cancer in Premenopausal WomenStatus unknownNCT02619123Not applicable
- The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.CompletedNCT02618538
- Spot tm Tattooing of Biopsied Axillary Lymph Nodes With Ultrasound Guided in Breast Cancer Patients Prior to SurgeryStatus unknownNCT02617264Not applicable
- Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving SurgeryStatus unknownNCT02617043Phase 2
- Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast CancersStatus unknownNCT02616848Phase 1
- Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase InhibitorsCompletedNCT02616744Phase 2
- A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast CancerWithdrawnNCT02616224
- HER2+ Breast Cancer Neo-Adjuvant Coordination of Care ProgramCompletedNCT02616133
- Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer SurvivorsCompletedNCT02615054
- IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast CarcinomaCompletedNCT02614833Phase 2